Atlas Trials

Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin

Clinical trial NCT05376969 · COMPLETED

Trial details

NCT number
NCT05376969
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
T2DM (Type 2 Diabetes Mellitus)
Start date
2021-05-25
Primary completion
2022-05-16
Enrollment
159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.